|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1993)) |
IUPAC Name ![]() |
| (3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 6547 | fluvastatin |
Synonyms ![]() |
| Canef® |
| Lescol® |
Database Links ![]() |
|
| CAS Registry No. | 93957-54-1 (source: Scifinder) |
| ChEBI | CHEBI:38561 |
| ChEMBL Ligand | CHEMBL1078 |
| DrugBank Ligand | DB01095 |
| PubChem CID | 446155 |
| RCSB PDB Ligand | 115 |
| Search Google for chemical match using the InChIKey | FJLGEFLZQAZZCD-MCBHFWOFSA-N |
| Search Google for chemicals with the same backbone | FJLGEFLZQAZZCD |
| Search PubMed clinical trials | fluvastatin |
| Search PubMed titles | fluvastatin |
| Search PubMed titles/abstracts | fluvastatin |
| Wikipedia | Fluvastatin |
| Comments |
| Fluvastatin is a member of the cholesterol-lowering statin family of drugs. The approved drug is a racemic mixture of a 3R, 5S isomer and a 3S, 5R isomer, and this is supported by the INN document which also indicates a racemate. The 3R, 5S isomer (shown here, and in the PubChem link above) is more pharmacologically active [1,4]. The other isomer is represented by CID 1548972. Representations of the stereochemistry of fluvastatin shown on the resources linked to above may vary from the structure shown here. The majority of the references we cite for our biological activity data do not specify whether the racemate or a specific stereoisomer were used in their experiments. |